These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29987143)

  • 21. The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
    Horta AL; Figueiredo VP; Leite ALJ; Costa GP; Menezes APJ; Ramos CO; Pedrosa TCF; Bezerra FS; Vieira PMA; Talvani A
    Mem Inst Oswaldo Cruz; 2018 Oct; 113(11):e180271. PubMed ID: 30365644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
    Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy.
    García MC; Eberhardt N; Sanmarco LM; Ponce NE; Jimenez-Kairuz AF; Aoki MP
    Eur J Pharm Sci; 2021 Sep; 164():105912. PubMed ID: 34133985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis?
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Pharmacol Res; 2020 Aug; 158():104907. PubMed ID: 32416214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.
    Valdez RH; Tonin LT; Ueda-Nakamura T; Silva SO; Dias Filho BP; Kaneshima EN; Yamada-Ogatta SF; Yamauchi LM; Sarragiotto MH; Nakamura CV
    Antimicrob Agents Chemother; 2012 Jan; 56(1):507-12. PubMed ID: 22037851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
    Bustamante JM; Craft JM; Crowe BD; Ketchie SA; Tarleton RL
    J Infect Dis; 2014 Jan; 209(1):150-62. PubMed ID: 23945371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
    Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
    Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
    Batista Dda G; Batista MM; de Oliveira GM; Britto CC; Rodrigues AC; Stephens CE; Boykin DW; Soeiro Mde N
    PLoS One; 2011; 6(7):e22155. PubMed ID: 21814568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
    Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
    Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
    Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
    Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II.
    Sarto MPM; Lucas da Silva HF; de Souza Fernandes N; de Abreu AP; Zanusso Junior G; de Ornelas Toledo MJ
    BMC Complement Med Ther; 2021 Feb; 21(1):77. PubMed ID: 33632196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
    Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
    PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in
    Barbosa JMC; Pedra-Rezende Y; Pereira LD; de Melo TG; Barbosa HS; Lannes-Vieira J; de Castro SL; Daliry A; Salomão K
    Front Cell Infect Microbiol; 2022; 12():975931. PubMed ID: 36093188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.